Table A5: Cannabis
| Prevalence estimates | Entrants into treatment during the year | ||||||
|---|---|---|---|---|---|---|---|
| General population | School population | Cannabis clients as % of treatment entrants | |||||
| Year of survey | Lifetime, adults (15–64) | Last 12 months, young adults (15–34) | Lifetime, students (15–16) | All entrants | First-time entrants | Previously treated entrants | |
| Country | % | % | % | % (count) | % (count) | % (count) | |
| Belgium | 2013 | 15 | 10.1 | 17 | 31.9 (3 737) | 51.6 (2 065) | 21.3 (1 582) |
| Bulgaria 1 | 2012 | 7.5 | 8.3 | 27 | 3.2 (58) | 8.4 (27) | 0.7 (7) |
| Czech Republic | 2015 | 29.5 | 18.8 | 37 | 11.8 (1 195) | 16.4 (776) | 7.8 (419) |
| Denmark | 2013 | 35.6 | 17.6 | 12 | 70.9 (3 338) | 79 (1 783) | 62.5 (1 430) |
| Germany 3 | 2015 | 27.2 | 13.3 | 19 | 39.1 (34 108) | 56.9 (15 168) | 31.2 (18 940) |
| Estonia | 2008 | – | 13.6 | 25 | 3.5 (10) | 7.9 (5) | 1.2 (2) |
| Ireland | 2015 | 27.9 | 13.8 | 19 | 28.3 (2 681) | 45.2 (1 693) | 16.8 (918) |
| Greece | – | – | – | 9 | 19.4 (789) | 34.2 (539) | 9.8 (240) |
| Spain | 2015 | 31.5 | 17.1 | 27 | 33.7 (16 478) | 48.1 (11 386) | 16.4 (3 084) |
| France | 2014 | 40.9 | 22.1 | 31 | 60.4 (29 621) | 74.9 (11 855) | 37.6 (6 391) |
| Croatia | 2015 | 19.4 | 16.0 | 21 | 12.8 (967) | 62 (526) | 6.5 (432) |
| Italy | 2014 | 31.9 | 19.0 | 27 | 19.5 (9 225) | 28 (5 810) | 12.9 (3 415) |
| Cyprus | 2016 | 12.1 | 4.3 | 7 | 58.8 (469) | 75.9 (330) | 38 (122) |
| Latvia | 2015 | 9.8 | 10.0 | 17 | 23.3 (175) | 35.5 (139) | 10 (36) |
| Lithuania | 2012 | 10.5 | 5.1 | 18 | 3.5 (89) | 11.9 (47) | 1.6 (33) |
| Luxembourg | – | – | – | – | 23.1 (67) | 58.3 (14) | 19.9 (43) |
| Hungary 3 | 2015 | 7.4 | 3.5 | 13 | 56.2 (2 420) | 62.7 (1 854) | 41.4 (458) |
| Malta | 2013 | 4.3 | – | 13 | 8.9 (158) | 29.1 (67) | 5.9 (91) |
| Netherlands | 2015 | 25.6 | 16.1 | 22 | 47.3 (5 202) | 55.5 (3 625) | 35.4 (1 577) |
| Austria | 2015 | 23.6 | 14.1 | 20 | 29.2 (1 063) | 54.4 (711) | 15.1 (352) |
| Poland | 2014 | 16.2 | 9.8 | 24 | 28 (2 525) | 36.3 (1 558) | 20.3 (901) |
| Portugal | 2012 | 9.4 | 5.1 | 15 | 33.9 (934) | 50.8 (806) | 10.9 (128) |
| Romania | 2013 | 4.6 | 3.3 | 8 | 39.3 (1 272) | 54.8 (1 137) | 9.5 (98) |
| Slovenia | 2012 | 15.8 | 10.3 | 25 | 14.2 (45) | 38.6 (34) | 4.8 (11) |
| Slovakia | 2015 | 15.8 | 9.3 | 26 | 24.6 (616) | 35.7 (430) | 13.7 (169) |
| Finland | 2014 | 21.7 | 13.5 | 8 | 20.7 (136) | 35.7 (99) | 9.8 (37) |
| Sweden 4 5 | 2015 | 14.7 | 7.3 | 7 | 11.1 (3 924) | 16.9 (2 113) | 7.9 (1 752) |
| United Kingdom 2 4 | 2015 | 29.4 | 11.3 | 19 | 25.9 (31 129) | 46.3 (18 345) | 15.8 (12 686) |
| Turkey | 2011 | 0.7 | 0.4 | – | 6 (653) | 7.7 (416) | 4.3 (237) |
| Norway 4 | 2015 | 20.9 | 8.6 | 7 | 27.2 (1 609) | – | – |
| European Union | – | 26.3 | 13.9 | – | 31.5 (152 431) | 46.2 (82 942) | 19.9 (55 354) |
| EU, Turkey and Norway | – | – | – | – | 30.9 (154 693) | 45.1 (83 358) | 19.6 (55 591) |
NB
Prevalence estimates for the school population are taken from national school surveys or the ESPAD project. Due to uncertainty of data collection procedures, Latvia data may not be comparable.
- Prevalence estimates for the general population refer to Flanders only. ↩
- Prevalence estimates for the general population refer to England and Wales only. ↩
- Age range for prevalence estimates in the general population: 18–64, 18–34. ↩
- Age range for prevalence estimates in the general population: 16–64, 16–34. ↩
- First-time and previously treated entrants are available only for two of the three data sources available in Sweden and, therefore, not comparable with data for all entrants. ↩